AJNN
Academic Journal of Neurology and Neurosurgery

The Academic Journal of Neurology and Neurosurgery deals with Neurology and Neurosurgery accepts articles on these topics. Academic Journal of Neurology and Neurosurgery publishes original research articles, review articles, case reports, editorial commentaries, letters to the editor, educational articles, and conference/meeting announcements.

eISSN: 3023-6517
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Evaluation of cerebrospinal fluid opening pressure and protein levels in relation to clinical profile and recovery in idiopathic intracranial hypertension
Abstract
Aims: Idiopathic intracranial hypertension (IIH) is an increase in CSF pressure without any other primary cause such as hydrocephalus, mass lesion, or meningeal abnormality. Evaluation of the severity of the disease and management of the treatment in patients are important for clinicians, and different parameters such as blood biomarkers and cerebrospinal fluid (CSF) opening pressure or protein levels are investigated. This study aimed to review the cases with IIH and evaluate the relationship between CSF opening pressure and protein levels obtained at the first presentation and the patient's clinical findings.
Methods: The data of patients diagnosed with IIH between 2012 and 2024 were retrospectively reviewed in the hospital electronic database, and demographic, clinical findings, neuroimaging results, and CSF analysis results were documented. The association between CSF opening pressure and protein levels obtained at the first presentation and the patient's clinical profile was analyzed. SPSS version 25 program was used in the statistical analysis of the data. p<0.05 was found to be statistically significant.
Results: Among 56 cases, 47 patients (83.9%) were female. The median age was 35 years. Visual impairment was the most common symptom (n=42, 75.0%). The mean of the CSF opening pressure was 332.68 mmH20, and patients had protein levels with a median of 27.05 mg/dl. Median CSF protein levels were found to be statistically significantly higher in patients presenting with decreased vision compared to those without (p=0.031). The number of patients with severe papilledema and decreased visual acuity was found to be significantly higher in the high CSF pressure group (p=0.041, p=0.042). Also, the number of patients with recurrent symptoms during the follow-up period was found to be significantly higher in high-pressure group (p=0.045).
Conclusion: In this retrospective study, clinical, laboratory, and radiological profiles of IIH patients were examined. Elevated CSF opening pressure in patients was found to be associated with visual impairment, increased symptom recurrence during follow-up, and severe papilledema; however, no association was observed with overall clinical recovery. CSF protein level was found to be associated only with improvement in visual acuity during follow-up. These findings underscore the need for multicenter studies to be conducted on this subject with a larger patient population to define the parameters and associations with the clinical course and prognosis.

Keywords : Idiopathic intracranial hypertension, headache, cerebrospinal fluid, protein, opening pressure

Download Article


1. Bouthour W, Bruce BB, Newman NJ, Biousse V. Factors associated with vision loss in idiopathic intracranial hypertension patients with severe papilledema. Eye. 2025;39(1):185-191. doi:10.1038/s41433-024-03408-3
2. Cho KH, Baek SH, Kim SH, et al. Clinical profile and treatment outcomes of idiopathic intracranial hypertension: a multicenter study from Korea. J Headache Pain. 2024;25(1):106. doi:10.1186/s10194-024-01794-3
3. Thurtell MJ. Idiopathic intracranial hypertension. Continuum (Minneap Minn). 2019;25(5):1289-1309. doi:10.1212/CON.0000000000000770
4. Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985; 5(1):55-56.
5. Sinclair AJ, Burdon MA, Nightingale PG, et al. Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension. J Neurol. 2012;259(7):1406-1412. doi:10.1007/s00415-011-6365-6
6. Miah L, Strafford H, Fonferko-Shadrach B, et al. Incidence, prevalence, and health care outcomes in idiopathic intracranial hypertension: a population study. Neurology. 2021;96(8):e1251-e1261. doi:10.1212/WNL.0000000000011463
7. Tian T. Clinical characteristics of patients with idiopathic intracranial hypertension in China. Cureus. 2024;16(7):e64990. doi:10.7759/cureus. 64990
8. Keskın AO, Idiman F, Kaya D, Bircan B. Idiopathic intracranial hypertension: etiological factors, clinical features, and prognosis. Noro Psikiyatr Ars. 2018;57(1):23-26. doi:10.5152/npa.2017.12558
9. Rosenblatt A, Klein A, Roemer S, et al. Idiopathic intracranial hypertension-a comparison of clinical characteristics between 4 medical centers in different geographic regions of the world. J Neuroophthalmol. 2016;36(3):280-284. doi:10.1097/WNO.0000000000000402
10. Sharma B, Seervi N, Sharma V, Panagariya A, Goel D. Clinical and radiological profile of 122 cases of idiopathic intracranial hypertension in a tertiary care centre of India: an observational study. Neurol India. 2022;70(2):704-709. doi:10.4103/0028-3886.344644
11. Akhter A, Schulz L, Inger HE, McGregor JM. Current indications for management options in pseudotumor cerebri. Neurol Clin. 2022;40(2): 391-404. doi:10.1016/j.ncl.2021.11.011
12. Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol. 2014;71(6):693-701. doi:10.1001/jamaneurol.2014.133
13. Serodio M, Cabral G, Meira B, Caetano A, Viana-Baptista M. Headache phenotypes in idiopathic intracranial hypertension and its short-term outcomes: a retrospective case series study. J Clin Med Res. 2024;16(2-3): 118-123. doi:10.14740/jocmr5141
14. Takkar A, Goyal MK, Bansal R, Lal V. Clinical and neuro-ophthalmologic predictors of visual outcome in idiopathic intracranial hypertension. Neuro-Ophthalmology. 2018;42(4):201-208. doi:10.1080/ 01658107.2017.1400570
15. Bsteh G, Marik W, Krajnc N, et al. MRI features of idiopathic intracranial hypertension are not prognostic of visual and headache outcome. J Headache Pain. 2023;24(1):97. doi:10.1186/s10194-023-01641-x
16. Kattah JC, Pula JH, Mejico LJ, McDermott MP, Kupersmith MJ, Wall M. CSF pressure, papilledema grade, and response to acetazolamide in the idiopathic intracranial hypertension treatment trial. J Neurol. 2015; 262(10):2271-2274. doi:10.1007/s00415-015-7838-9
17. Hsu HT, Cheng HC, Hou TW, et al. Idiopathic intracranial hypertension in Asians: a retrospective dual-center study. J Headache Pain. 2024;25(1):144. doi:10.1186/s10194-024-01852-w
18. Berezovsky DE, Bruce BB, Vasseneix C, Peragallo JH, Newman NJ, Biousse V. Cerebrospinal fluid total protein in idiopathic intracranial hypertension. J Neurol Sci. 2017;381:226-229. doi:10.1016/j.jns.2017.08. 3264
Article available in :
Volume 2, Issue 3, 2025
Page : 56-61
https://doi.org/10.51271/AJNN-0034
Article Information
Received : 01 Eyl 2025
Accepted : 29 Eyl 2025
Published : 30 Eyl 2025
Corresponding Author :

İlkin İyigündoğdu: Department of Neurology, Faculty of Medicine, Baskent University, Ankara, Turkiye

[email protected]
Citation : İyigündoğdu İ. Evaluation of cerebrospinal fluid opening pressure and protein levels in relation to clinical profile and recovery in idiopathic intracranial hypertension. Acad J Neurol Neurosurg. 2025;2(3):56-61.

Read: 7
Download : 4
Cited: 0
_Footer